Notice: This company has been marked as potentially delisted and may not be actively trading. Alterity Therapeutics (PRAN) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsHeadlinesTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Alterity Therapeutics Appoints New Company SecretaryNovember 19 at 2:22 PM | markets.businessinsider.comAlterity Therapeutics appoints Abby Macnish Niven as secretaryNovember 19 at 2:22 PM | markets.businessinsider.comAlterity Therapeutics Unveils New Advances for MSA TrackingNovember 12, 2024 | markets.businessinsider.comAlterity Therapeutics announces new publication on ATH434November 6, 2024 | markets.businessinsider.comAlterity Therapeutics: Innovative Approach with ATH434November 6, 2024 | markets.businessinsider.comAlterity Therapeutics Reveals Positive MSA Trial DataOctober 31, 2024 | markets.businessinsider.comAlterity Therapeutics Prepares for 2024 Annual General MeetingOctober 23, 2024 | markets.businessinsider.comAlterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®October 2, 2024 | markets.businessinsider.comAlterity Therapeutics Appoints Abby Macnish Niven To Succeed Phillip Hains As CFOSeptember 30, 2024 | markets.businessinsider.com‘Holy Grail’ – Alterity Therapeutics aims to slow progression of Parkinson’s diseaseSeptember 18, 2024 | msn.comKazia Therapeutics Limited (KZIA)April 18, 2024 | finance.yahoo.comAlterity Therapeutics Says Phillip Hains To Replace Kathryn Andrews As CFODecember 21, 2023 | nasdaq.comAlterity Therapeutics Appoints Phillip Hains as Chief Financial OfficerDecember 21, 2023 | markets.businessinsider.comAlterity jumps after promising data on Parkinson's candidateDecember 4, 2023 | seekingalpha.comWhy Is Alterity Therapeutics (ATHE) Stock Up 150% Today?December 4, 2023 | investorplace.comAxsome Therapeutics Inc AXSMOctober 31, 2023 | morningstar.comADRs End Higher; Orchard Therapeutics PLC Climbs 96%October 8, 2023 | morningstar.comAlterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson's and Alzheimer'sAugust 23, 2023 | technews.tmcnet.comAlterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer's DiseaseMarch 14, 2023 | technews.tmcnet.comAlterity: Study Shows ATH434 Prevents Loss of Brain Cells in Parkinson's Disease Animal ModelJanuary 30, 2023 | marketwatch.comAlterity Therapeutics Stock (OTC:PRNAF), Analyst Ratings, Price Targets, PredictionsSeptember 26, 2022 | benzinga.comHere's Why Alterity Therapeutics Shares Are VolatileSeptember 20, 2022 | msn.com Get Alterity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide PRAN Media Mentions By Week PRAN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRAN News Sentiment▼0.000.48▲Average Medical News Sentiment PRAN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRAN Articles This Week▼20▲PRAN Articles Average Week Get Alterity Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Lumos Pharma News Today RAPT Therapeutics News Today NextCure News Today Carisma Therapeutics News Today Lexaria Bioscience News Today Clene News Today Lantern Pharma News Today Acasti Pharma News Today ProMIS Neurosciences News Today Ocuphire Pharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRAN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Alterity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
